38,150
Views
250
CrossRef citations to date
0
Altmetric
Coronaviruses

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

, , , , , , , , , & ORCID Icon show all
Pages 1-5 | Received 07 Dec 2021, Accepted 08 Dec 2021, Published online: 21 Dec 2021

References

  • Callaway E. Heavily mutated Omicron variant puts scientists on alert. Nature. 2021;600:21. doi:10.1038/d41586-021-03552-w.
  • WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.
  • GISAID. 2021. https://www.gisaid.org/hcov19-variants/.
  • Li Q, Nie J, Wu J, et al. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape. Cell. 2021;184:2362–2371.e9. doi:10.1016/j.cell.2021.02.042.
  • Garcia-Beltran WF, Lam EC, St.Dennis K, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021;184:2523. doi:10.1016/j.cell.2021.04.006.
  • Zhang L, Cui Z, Li Q, et al. Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization. Commun Biol. 2021;4:1196. doi:10.1038/s42003-021-02728-4.
  • Wang M, Zhang L, Li Q, et al. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination. Emerg Microbes Infect. 2021: 1–30. doi:10.1080/22221751.2021.2008775.
  • Pulliam JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. J medRxiv (2021). 2021.2011.2011.21266068. doi:10.1101/2021.11.11.21266068.
  • Shi R, Shan C, Duan X, et al. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020;584:120–124. doi:10.1038/s41586-020-2381-y.
  • Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. doi:10.1038/s41591-021-01377-8.
  • Nie J, Li Q, Wu J, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020;9:680–686. doi:10.1080/22221751.2020.1743767.
  • ] Nie J, Li Q, Wu J, et al. Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. Nat Protoc. 2020;15:3699–3715. doi:10.1038/s41596-020-0394-5.